Niki Hisateru, Haraguchi Naoki, Aoki Takafumi, Ikezawa Hiroko, Ouchi Kazuo, Okuda Ryuzo, Kakihana Masataka, Shima Hiroaki, Suda Yasunori, Takao Masato, Tanaka Yasuhito, Watanabe Kota, Tatsunami Shinobu
Department of Orthopaedic Surgery, St. Marianna University School of Medicine, Japan.
Department of Orthopaedic Surgery, Tokyo Metropolitan Police Hospital, Japan.
J Orthop Sci. 2017 Jul;22(4):737-742. doi: 10.1016/j.jos.2017.04.005. Epub 2017 May 10.
In this study, we investigated the responsiveness of the Self-Administered Foot Evaluation Questionnaire (SAFE-Q) for patient's assessment before and after hallux valgus surgery.
Patient-reported answers on the SAFE-Q and Short Form-36 (SF-36) before and at a mean of 3-4 and 9-12 months after hallux valgus surgery were analyzed. Data of 100 patients (92 women, eight men) from 36 institutions throughout Japan were used for analysis.
In all subscales of the SAFE-Q, the trend of increased scores after surgery was statistically significant (P < 0.001). Among the patients with available scores both before and at 9-12 months after surgery (n = 66), the largest effect sizes (ESs) were observed for shoe-related (1.60), pain and pain-related (1.05), and general health and well-being (0.84) scales. In the SF-36 (n = 64), the largest ES was observed for the bodily pain scale (0.86). Less notable changes were observed for the remaining SF-36 domains.
The SAFE-Q is the first patient-reported outcome measure which includes a quality of life assessment of shoes. In our cohort, the most remarkable responsiveness was observed for the shoe-related subscale. Based on its responsiveness, the SAFE-Q appears to be sufficient for evaluation of foot-related quality of life before and after surgery.
在本研究中，我们调查了自我管理足部评估问卷（SAFE-Q）在拇外翻手术前后对患者评估的反应性。
分析了患者在拇外翻手术前、术后平均3 - 4个月和9 - 12个月时对SAFE-Q和简短健康调查问卷（SF-36）的回答。使用了来自日本各地36家机构的100名患者（92名女性，8名男性）的数据进行分析。
在SAFE-Q的所有子量表中，术后得分增加的趋势具有统计学意义（P < 0.001）。在手术前和术后9 - 12个月均有可用分数的患者中（n = 66），与鞋子相关的量表（1.60）、疼痛及与疼痛相关的量表（1.05）以及总体健康和幸福感量表（0.84）观察到最大的效应量（ESs）。在SF-36（n = 64）中，身体疼痛量表观察到最大的ES（0.86）。其余SF-36领域观察到较不明显的变化。
SAFE-Q是首个纳入鞋子生活质量评估的患者报告结局指标。在我们的队列中，与鞋子相关的子量表观察到最显著的反应性。基于其反应性，SAFE-Q似乎足以评估手术前后与足部相关的生活质量。
